ANRO
Price
$3.67
Change
+$0.16 (+4.56%)
Updated
Sep 5 closing price
Capitalization
99.37M
73 days until earnings call
NUVL
Price
$80.89
Change
+$1.22 (+1.53%)
Updated
Sep 5 closing price
Capitalization
5.83B
61 days until earnings call
Interact to see
Advertisement

ANRO vs NUVL

Header iconANRO vs NUVL Comparison
Open Charts ANRO vs NUVLBanner chart's image
Alto Neuroscience
Price$3.67
Change+$0.16 (+4.56%)
Volume$36.32K
Capitalization99.37M
Nuvalent
Price$80.89
Change+$1.22 (+1.53%)
Volume$438.32K
Capitalization5.83B
ANRO vs NUVL Comparison Chart in %
Loading...
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANRO vs. NUVL commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a Hold and NUVL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ANRO: $3.67 vs. NUVL: $80.89)
Brand notoriety: ANRO and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 34% vs. NUVL: 93%
Market capitalization -- ANRO: $99.37M vs. NUVL: $5.83B
ANRO [@Biotechnology] is valued at $99.37M. NUVL’s [@Biotechnology] market capitalization is $5.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANRO and NUVL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 4 TA indicator(s) are bullish while NUVL’s TA Score has 6 bullish TA indicator(s).

  • ANRO’s TA Score: 4 bullish, 4 bearish.
  • NUVL’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than ANRO.

Price Growth

ANRO (@Biotechnology) experienced а -0.27% price change this week, while NUVL (@Biotechnology) price change was +5.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

ANRO is expected to report earnings on Nov 18, 2025.

NUVL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($5.83B) has a higher market cap than ANRO($99.4M). NUVL YTD gains are higher at: 3.334 vs. ANRO (-13.239). ANRO has higher annual earnings (EBITDA): -62.3M vs. NUVL (-362.01M). NUVL has more cash in the bank: 1.01B vs. ANRO (148M). ANRO (0) and NUVL (0) have equivalent revenues.
ANRONUVLANRO / NUVL
Capitalization99.4M5.83B2%
EBITDA-62.3M-362.01M17%
Gain YTD-13.2393.334-397%
P/E RatioN/AN/A-
Revenue00-
Total Cash148M1.01B15%
Total Debt27.3MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ANRONUVL
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
89%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 18 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGPTF0.310.02
+7.09%
SAGE POTASH CORP
VDMCY7.860.12
+1.60%
Vodacom Group Ltd.
ASFT0.25N/A
N/A
AppSoft Technologies, Inc.
MOHCF23.00N/A
N/A
Motor Oil (Hellas) Corinth Refineries S.A.
XPPLF10.64-1.36
-11.33%
XP Power Ltd.

ANRO and

Correlation & Price change

A.I.dvisor tells us that ANRO and NUVL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANRO and NUVL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
+4.56%
NUVL - ANRO
29%
Poorly correlated
+1.53%
XTLB - ANRO
27%
Poorly correlated
N/A
CGON - ANRO
23%
Poorly correlated
+6.88%
IRON - ANRO
23%
Poorly correlated
+0.95%
NTLA - ANRO
23%
Poorly correlated
+3.79%
More